Washington, DC - October 19-23, 2022; Glasgow, Scotland and virtual - October 23-26, 2022
In expanded multivariable analyses from ATLAS, ATLAS-2M, and FLAIR of PWH receiving LA CAB plus RPV, factors most predictive of confirmed virologic failure were preexisting rilpivirine resistance associated mutations and HIV-1 subtype A6/A1.